{
     "PMID": "29191454",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20180112",
     "LR": "20180213",
     "IS": "1096-0333 (Electronic) 0041-008X (Linking)",
     "VI": "338",
     "DP": "2018 Jan 1",
     "TI": "Fullerene (C60) particle size implications in neurotoxicity following infusion into the hippocampi of Wistar rats.",
     "PG": "197-203",
     "LID": "S0041-008X(17)30467-2 [pii] 10.1016/j.taap.2017.11.022 [doi]",
     "AB": "The buckminsterfullerene (C60) is considered as a relevant candidate for drug and gene delivery to the brain, once it has the ability to cross the blood-brain barrier. However, the biological implications of this nanomaterial are not fully understood, and its safety for intracerebral delivery is still debatable. In this study, we investigated if C60 particle size could alter its biological effects. For this, two aqueous C60 suspensions were used with maximum particle size up to 200nm and 450nm. The suspensions were injected in the hippocampus, the main brain structure involved in memory processing and spatial localization. In order to assess spatial learning, male Wistar rats were tested in Morris water maze, and the hippocampal BDNF protein levels and gene expression were analyzed. Animals treated with C60 up to 450nm demonstrated impaired spatial memory with a significant decrease in BDNF protein levels and gene expression. However, an enhanced antioxidant capacity was observed in both C60 treatments. A decrease in reactive oxygen species levels was observed in the treatments with suspensions containing particles measuring with up to 450nm. Thiobarbituric acid reactive substances, glutamate cysteine ligase, and glutathione levels showed no alterations among the different treatments. In conclusion, different particle sizes of the same nanomaterial can lead to different behavioral outcomes and biochemical parameters in brain tissue.",
     "CI": [
          "Copyright (c) 2017 Elsevier Inc. All rights reserved."
     ],
     "FAU": [
          "Kraemer, Andrea Barbosa",
          "Parfitt, Gustavo Morrone",
          "Acosta, Daiane da Silva",
          "Bruch, Gisele Eva",
          "Cordeiro, Marcos Freitas",
          "Marins, Luis Fernando",
          "Ventura-Lima, Juliane",
          "Monserrat, Jose Maria",
          "Barros, Daniela Marti"
     ],
     "AU": [
          "Kraemer AB",
          "Parfitt GM",
          "Acosta DDS",
          "Bruch GE",
          "Cordeiro MF",
          "Marins LF",
          "Ventura-Lima J",
          "Monserrat JM",
          "Barros DM"
     ],
     "AD": "Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Programa de Pos-Graduacao em Ciencias Fisiologicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Electronic address: barrosdm@yahoo.com.br.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20171127",
     "PL": "United States",
     "TA": "Toxicol Appl Pharmacol",
     "JT": "Toxicology and applied pharmacology",
     "JID": "0416575",
     "RN": [
          "0 (Brain-Derived Neurotrophic Factor)",
          "0 (Fullerenes)",
          "0 (Reactive Oxygen Species)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain-Derived Neurotrophic Factor/analysis",
          "Fullerenes/*toxicity",
          "Hippocampus/*drug effects/metabolism",
          "Male",
          "Neurotoxicity Syndromes/*etiology",
          "Particle Size",
          "Rats",
          "Rats, Wistar",
          "Reactive Oxygen Species/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*Buckminsterfullerene",
          "*Hippocampus",
          "*Learning",
          "*Memory",
          "*Nanotechnology"
     ],
     "EDAT": "2017/12/02 06:00",
     "MHDA": "2018/01/13 06:00",
     "CRDT": [
          "2017/12/02 06:00"
     ],
     "PHST": [
          "2017/08/25 00:00 [received]",
          "2017/11/23 00:00 [revised]",
          "2017/11/26 00:00 [accepted]",
          "2017/12/02 06:00 [pubmed]",
          "2018/01/13 06:00 [medline]",
          "2017/12/02 06:00 [entrez]"
     ],
     "AID": [
          "S0041-008X(17)30467-2 [pii]",
          "10.1016/j.taap.2017.11.022 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Toxicol Appl Pharmacol. 2018 Jan 1;338:197-203. doi: 10.1016/j.taap.2017.11.022. Epub 2017 Nov 27.",
     "term": "hippocampus"
}